常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.21/-0.45
|
|
企业价值
28.11M
|
| 资产负债 |
|
每股账面净值
-0.91
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
8.68M
|
|
每股收益
4.38
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/11/16 17:40 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Vyome Holdings Inc is a clinical stage specialty pharmaceutical company working to treat immuno-inflammatory diseases including rare indications of unmet need with next-generation therapeutic solutions. |

4.87 
